## Abstract Hepatocellular carcinoma (HCC) is a major health problem in the AsiaβPacific region, with high incidence and mortality rate. There is currently no effective treatment for inoperable cases that represent the vast majority of patients. In the present study, we report that in vitro treatme
β¦ LIBER β¦
p53 regulates Cdc2 independently of inhibitory phosphorylation to reinforce radiation-induced G2 arrest in human cells
β Scribed by Winters, Z E; Ongkeko, W M; Harris, A L; Norbury, C J
- Book ID
- 110061478
- Publisher
- Nature Publishing Group
- Year
- 1998
- Tongue
- English
- Weight
- 497 KB
- Volume
- 17
- Category
- Article
- ISSN
- 0950-9232
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
SarCNU-induced G2/M arrest in hepatoma c
β
Huynh Hung; Chow Kad Hoe Pierce; Soo Khee Chee; Panasci Lawrence; Nguyen Thanh H
π
Article
π
2005
π
John Wiley and Sons
π
English
β 341 KB
Bendamustine induces G2 cell cycle arres
β
Leander Gaul; Sonja Mandl-Weber; Philipp Baumann; Bertold Emmerich; Ralf Schmidm
π
Article
π
2007
π
Springer-Verlag
π
English
β 513 KB
p14ARF induces G2 arrest and apoptosis i
β
Eymin, BΓ©atrice; Leduc, Camille; Coll, Jean-Luc; Brambilla, Elisabeth; Gazzeri,
π
Article
π
2003
π
Nature Publishing Group
π
English
β 638 KB
Induction of p53-independent Apoptosis A
β
Arita, Daisaku ;Kambe, Mariko ;Ishioka, Chikashi ;Kanamaru, Ryunosuke
π
Article
π
1997
π
Wiley (Blackwell Publishing)
π
English
β 475 KB
Inactivation of p53 in normal human cell
β
Jocelyn CΓ©raline; GaΓ«l Deplanque; Brigitte Duclos; Jean-Marc Limacher; Amor Hajr
π
Article
π
1998
π
John Wiley and Sons
π
French
β 206 KB
π 2 views
p53 mutations are found in about 70% of human cancers. In order to evaluate the role of these mutations in response to chemotherapeutic agents, it is important to distinguish between p53 response to DNA-damaging agents in normal and in tumour cells. Here, using normal human fibroblasts (NHFs), we sh
Oroxylin A induces G2/M phase cell-cycle
β
Yong Yang; Yang Hu; Hong-Yan Gu; Na Lu; Wei Liu; Qi Qi; Li Zhao; Xiao-Tang Wang;
π
Article
π
2008
π
Pharmaceutical Press
π
English
β 666 KB